Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...
This report provides useful evidence that EABR mRNA is at least as effective as standard S mRNA vaccines for the SARS-CoV-2 booster vaccine. Although the methodology and the experimental approaches ...
While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...
Background Interstitial fibrosis in lupus nephritis (LN) is often infiltrated by immune cells but typically regarded as ...
Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...
A new vaccine targeting the deadly Crimean-Congo hemorrhagic fever virus shows rapid protection in mice, working within days and lasting over a year.
Key presentation unveiled Acuitas' Next-Generation LNP Advancements, which is designed to enhance potency and safety, expand delivery beyond the liver, and enable broader therapeutic impact ...
"Our goal was to create a human system that captures how the liver and immune system interact in patients," El Abdellaoui Soussi says. "By integrating patient-specific genetics and immune responses, ...
STOCKHOLM (AP) — Three scientists won the Nobel Prize in medicine Monday for discoveries about how the immune system knows to attack germs and not our own bodies. The work by Mary E. Brunkow, Fred ...
STOCKHOLM (AP) — Mary E. Brunkow, Fred Ramsdell and Dr. Shimon Sakaguchi won the Nobel Prize in medicine on Monday for their discoveries concerning peripheral immune tolerance. Brunkow, 64, is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback